170 related articles for article (PubMed ID: 14679275)
1. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee.
Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B;
JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275
[TBL] [Abstract][Full Text] [Related]
2. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
Tan L;
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
[TBL] [Abstract][Full Text] [Related]
3. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.
Klein JO; Myers MG
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139
[TBL] [Abstract][Full Text] [Related]
4. Vaccine shortages eliminate possibility for excess capacity in stockpiles.
Congeni BL
Pediatr Ann; 2004 Sep; 33(9):577-83. PubMed ID: 15462572
[TBL] [Abstract][Full Text] [Related]
5. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
[TBL] [Abstract][Full Text] [Related]
6. The United States pediatric vaccine stockpile program.
Lane KS; Chu SY; Santoli JM
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
[TBL] [Abstract][Full Text] [Related]
7. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
Shen AK; Rodewald LE; Birkhead GS
Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
[TBL] [Abstract][Full Text] [Related]
8. Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
JAMA; 1999 Jul; 282(4):363-70. PubMed ID: 10432034
[TBL] [Abstract][Full Text] [Related]
9. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
Pisano W
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
[TBL] [Abstract][Full Text] [Related]
10. Financing vaccines in the 21st century: recommendations from the National Vaccine Advisory Committee.
Hinman AR;
Am J Prev Med; 2005 Jul; 29(1):71-5. PubMed ID: 15958255
[TBL] [Abstract][Full Text] [Related]
11. Vaccine shortages: history, impact, and prospects for the future.
Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL
Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116
[TBL] [Abstract][Full Text] [Related]
12. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
13. Addressing the vaccine financing conundrum.
Hinman AR
Health Aff (Millwood); 2005; 24(3):701-4. PubMed ID: 15886163
[TBL] [Abstract][Full Text] [Related]
14. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
Rodewald LE; Orenstein WA; Mason DD; Cochi SL
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
[TBL] [Abstract][Full Text] [Related]
15. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
Shrestha SS; Wallace GS; Meltzer MI
Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
[TBL] [Abstract][Full Text] [Related]
16. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
Evans G
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
[TBL] [Abstract][Full Text] [Related]
17. The National Vaccine Advisory Committee at 30: Impact and opportunity.
Thompson KM; Gellin BG; Hinman AR; Orenstein WA
Vaccine; 2018 Mar; 36(11):1330-1344. PubMed ID: 29422369
[TBL] [Abstract][Full Text] [Related]
18. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
Noah L
S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
[TBL] [Abstract][Full Text] [Related]
19. Vaccine supply, demand, and policy: a primer.
Muzumdar JM; Cline RR
J Am Pharm Assoc (2003); 2009; 49(4):e87-99. PubMed ID: 19589753
[TBL] [Abstract][Full Text] [Related]
20. Establishing government-operated vaccine programs: an industry perspective.
Paradiso PR
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S118-20. PubMed ID: 16447132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
